|
Real-world (RW) survival and outcomes with androgen receptor pathway inhibitor (ARPI) –doublet therapy in patients (pts) with de novo metastatic castration-sensitive prostate cancer (mCSPC). |
|
|
Research Funding - Astellas Scientific and Medical Affairs Inc (Inst); Blue Earth Diagnostics (Inst); Cedars-Sinai (Inst); Diasorin (Inst); Ferring (Inst); Genomic Health (Inst); Janssen (Inst); LungLife AI (Inst); MDxHealth (Inst); Merck (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Pfizer (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - Astellas Pharma; Pfizer |
Stock and Other Ownership Interests - Veru |
Research Funding - Astellas Pharma; Pfizer |
|
|
Employment - Astellas Pharma |
Stock and Other Ownership Interests - BioNano Genomics; Recursion Pharmaceuticals; Soligenix; Tonix Pharmaceuticals |
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
Stock and Other Ownership Interests - Myovant Sciences |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Blue Earth Diagnostics (Inst); Delfi Diagnostics (Inst); Exact Sciences (Inst); Ferring (Inst); Guardant Health (Inst); Janssen (Inst); LungLife AI (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Photocure (Inst); Prostatype Genomics (Inst); Reinvestment Partners (Inst) |
|
|
Employment - Astellas Pharma |
|
|
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Blue Earth Diagnostics (Inst); Delfi Technologies (Inst); Exact Sciences (Inst); Ferring (Inst); Guardant Health (Inst); Janssen (Inst); LungLife AI (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Photocure (Inst); Prostatype Genomics (Inst); Reinvestments Partners (Inst) |
|
|
Employment - Astellas Pharma; Lundbeck |
|
|
|
Stock and Other Ownership Interests - Pfizer; Pfizer (I) |
Research Funding - Astellas Amgen BioPharama; Pfizer |
Travel, Accommodations, Expenses - Pfizer |
|
|
|
|
|
Employment - Genomic Health (I) |
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; LynxDx; Merck; Myovant Sciences; Pfizer; Sanofi; Tempus |
Speakers' Bureau - AstraZeneca; Sanofi |
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst) |
Travel, Accommodations, Expenses - Sanofi |